Forwarded from Crypto News - Fast Market Moving⚡️
The most trusted , Verified ✅️ Crypto Community since 2017 ! Join today
https://t.me/+tvwGa6tMATxiODQ0
https://t.me/+tvwGa6tMATxiODQ0
Please open Telegram to view this post
VIEW IN TELEGRAM
Market
Novo Nordisk pills for weight loss might push the stock up 10-25% @Market
Novo Nordisk +10%, keep holding.
Expecting huge breakout soon.
Their pills is a fucking game changer!
@Market
Expecting huge breakout soon.
Their pills is a fucking game changer!
@Market
👍1
Market
Novo Nordisk +10%, keep holding. Expecting huge breakout soon. Their pills is a fucking game changer! @Market
Novo Nordisk partners with Amazon Web Services (AWS) for its cloud infrastructure, using services like Amazon Bedrock and SageMaker to accelerate drug discovery with AI, while also selling products like Novofine needles and Novopen devices on Amazon's retail platform for consumers. The relationship spans from deep tech collaboration (AI, data management) to direct-to-consumer sales of diabetes/obesity care supplies, with a recent Reuters report noting Amazon Pharmacy will offer Novo Nordisk's Wegovy pill
NVO stock +17% since posted here by @Market
NVO stock +17% since posted here by @Market
❤2👍1
Did you buy the NVO Novo Nordisk stock as we posted the signal and news?
Anonymous Poll
53%
yes
47%
no
👍2
Nike’s latest shoe drop — featuring a dotted outsole — sold out within hours, reinforcing strong brand demand. 👟
From an investment view, Nike (NKE) is trading around the mid-$60s, while Wall Street consensus targets ~$75–$80, implying moderate upside. Bullish analysts see higher potential if the turnaround accelerates; cautious voices flag a slower recovery, especially in China.
Under new CEO Elliott Hill, Nike is refocusing on core performance products, rebuilding wholesale partnerships, and tightening execution.
Bottom line: product hype boosts brand momentum, but sustained earnings improvement will determine the stock’s next leg.
@Market
From an investment view, Nike (NKE) is trading around the mid-$60s, while Wall Street consensus targets ~$75–$80, implying moderate upside. Bullish analysts see higher potential if the turnaround accelerates; cautious voices flag a slower recovery, especially in China.
Under new CEO Elliott Hill, Nike is refocusing on core performance products, rebuilding wholesale partnerships, and tightening execution.
Bottom line: product hype boosts brand momentum, but sustained earnings improvement will determine the stock’s next leg.
@Market
👍1